4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-19-000084
COO and SVP, R&D acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Johnston Lloyd P. · COO and SVP, R&D
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-07-23 | Exercise or conversion : show line 1 in the form | +10,000 | $0.47 | $4,700 | 11,606 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-07-23 | Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) | −10,000 | $0.47 | 2019-07-23 | 10,000 | 0 | D |
Loading xslF345X03/wf-form4_156408571299475.xml…